Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults
DC Field | Value | Language |
---|---|---|
dc.contributor.author | KIM, Woo Joo | - |
dc.contributor.author | SONG, Joon-young | - |
dc.contributor.author | HEE-JIN CHEONG | - |
dc.contributor.author | CHOI, WONSEOK | - |
dc.contributor.author | Noh Ji Yun | - |
dc.date.accessioned | 2021-09-03T07:38:13Z | - |
dc.date.available | 2021-09-03T07:38:13Z | - |
dc.date.created | 2021-06-21 | - |
dc.date.issued | 2013-07 | - |
dc.identifier.issn | 2287-3651 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/83902 | - |
dc.description.abstract | Purpose: To prepare for vaccine shortages under an influenza pandemic, several antigen-sparing strategies have been investigated. This study was aimed to evaluate the immunogenicity of influenza vaccine at reduced intradermal and full intramuscular dose. Materials and Methods: We compared the effect of one-fifth and one-half intradermal doses to the full intramuscular dose on immunogenicity in healthy young adults, using a commercial influenza vaccine. A hemagglutination inhibition assay was used to compare the immunogenicity of the vaccination methods. Results: The one-fifth intradermal dose (3 μg hemagglutinin antigen, HA) was given to 30 participants, the one-half intradermal dose (7.5 μg HA) was given to 30, and the full intramuscular dose (15 μg HA) was given to 32. No significant differences among injection routes and dosages were seen for seroprotection rate, seroconversion rate, or geometric mean titer (GMT) fold-increase for A/H1N1, A/H3N2, and B at around 4 weeks from vaccination. Although GMT for influenza B was significantly lower at six months for the one-fifth intradermal vaccination compared to the full-dose intramuscular vaccination (32.8 vs. 63.2, p=0.048), all three groups met the Evaluation of Medicinal Products (EMA) immunogenicity criteria through 1 to 6 mo | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN VACCINE SOCIETY | - |
dc.title | Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | KIM, Woo Joo | - |
dc.contributor.affiliatedAuthor | SONG, Joon-young | - |
dc.contributor.affiliatedAuthor | HEE-JIN CHEONG | - |
dc.contributor.affiliatedAuthor | CHOI, WONSEOK | - |
dc.contributor.affiliatedAuthor | Noh Ji Yun | - |
dc.identifier.doi | 10.7774/cevr.2013.2.2.115 | - |
dc.identifier.bibliographicCitation | CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, v.2, no.2, pp.115 - 119 | - |
dc.relation.isPartOf | CLINICAL AND EXPERIMENTAL VACCINE RESEARCH | - |
dc.citation.title | CLINICAL AND EXPERIMENTAL VACCINE RESEARCH | - |
dc.citation.volume | 2 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 115 | - |
dc.citation.endPage | 119 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.